Article
Impact of homologous recombination repair/BReast CAncer (BRCA) gene alterations on survival in a real-world setting of metastatic prostate cancer.
BJU international - 1 Jan 2025
Wenzel Mike, Hoeh Benedikt, Koll Florestan, Humke Clara, Fassl Anne, Reis Henning, Wild Peter, Steuber Thomas, Graefen Markus, Tilki Derya, Traumann Miriam, Banek Severine, Chun Felix K H, Mandel Philipp
Abstract excerpt
OBJECTIVE: To investigate alterations of homologous recombination repair (HRR) and especially BReast CAncer 1/2 (BRCA1/2) gene on overall survival (OS). Moreover, to explore the effect of inhibition of poly(ADP-ribose)-polymerase (PARPi) as systemic therapy for metastatic castration-resistant prostate cancer (mCRPC). PATIENTS AND METHODS: Of all HRR-screened patients with metastatic prostate cancer, baseline...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
